Literature DB >> 93048

The effect of dose loading and of double labelling with 57Co and 125I on the tissue distribution in animals.

C M Vos, G Westera, P J van der Jagt, B van Zanten.   

Abstract

Dose loading effects upon the performance of 57Co-bleomycin as a tumor localizing agent have been investigated in Rhabdomyosarcoma bearing Wag/Ry rats. The addition of non-radioactively labelled Co-bleomycin increased the relative uptake of 57Co-bleomycin in rapid growing tumors, but the addition of non-chelated bleomycin had no influence at all. In our experimental system, iodinated bleomycin generally labelled by reaction with ICl, was found to be an unsatisfactory tumor localizing agent. In order to combine the useful localizing properties of Co-bleomycin with the qualified detection properties of some iodine isotopes, we attempted to prepare bleomycin doubly labelled with Co and I. However, we were unable to prepare 57Co-125I-bleomycin by general labelling with ICl. This result indicates that both labels need the imidazole ring for the formation of a stable, labelled bleomycin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93048     DOI: 10.1007/bf00263311

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  I-131-labeling of proteins by the iodine monochloride method.

Authors:  R W Helmkamp; M A Contreras; W F Bale
Journal:  Int J Appl Radiat Isot       Date:  1967-11

Review 2.  Chemistry and mechanism of action of bleomycin.

Authors:  H Umezawa
Journal:  Fed Proc       Date:  1974-11

3.  DNA structures required for bleomycin binding.

Authors:  H Asakura; H Umezawa; M Hori
Journal:  J Antibiot (Tokyo)       Date:  1978-02       Impact factor: 2.649

4.  Studies of tumor metabolism--II. Mössbauer spectroscopy of 57Co-bleomycin.

Authors:  M R Zalutsky; A M Friedman; J C Sullivan; S L Ruby; G V Rayudu
Journal:  Int J Nucl Med Biol       Date:  1977-12

5.  Labelling of bleomycin with cobalt-57, indium-111, technetium-99m, mercury-197, lead-203, and copper-67.

Authors:  M A van de Poll; A Versluis; J J Rasker; H Jurjens; M G Woldring
Journal:  Nuklearmedizin       Date:  1976-04       Impact factor: 1.379

6.  Purification of bleomycins.

Authors:  H Umezawa; Y Suhara; T Takita; K Maeda
Journal:  J Antibiot (Tokyo)       Date:  1966-09       Impact factor: 2.649

7.  Preparation and chemical characterization of radioiodinated bleomycin.

Authors:  J Meyers; K Krohn; G DeNardo
Journal:  J Nucl Med       Date:  1975-09       Impact factor: 10.057

8.  Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.

Authors:  J J Rasker; A M Poll; H Beekhuis; M G Woldring; H O Nieweg
Journal:  J Nucl Med       Date:  1975-11       Impact factor: 10.057

9.  Comparison of I-bleomycin prepared by two methods stability and pharmacokinetics in tumor-bearing mice.

Authors:  K A Krohn; J Meyers; G L DeNardo
Journal:  Radiology       Date:  1977-01       Impact factor: 11.105

10.  A spectroscopic investigation of the metal binding site of bleomycin A2. The Cu(II) and Zn(II) derivatives.

Authors:  J C Dabrowiak; F T Greenaway; W E Longo; M Van Husen; S T Crooke
Journal:  Biochim Biophys Acta       Date:  1978-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.